• Archive for September, 2011

    BARDA supports development of oral radiation drug

    by  • 30 September 2011 • General News

    WASHINGTON–(BUSINESS WIRE)–A drug that can be taken orally to treat internal contamination from radiation after a radiological attack will be developed under a new contract issued today by the U.S. Department of Health and Human Services’ Biomedical Advanced Research and Development Authority (BARDA). Under the contract, Nanotherapeutics Inc. of Alachua, Fla., will conduct studies to [...]

    Read more →

    Galectin Therapeutics Posts New Corporate Presentation Video to its Website

    by  • 30 September 2011 • General News

    NEWTON, Mass.–(BUSINESS WIRE)–Galectin Therapeutics Inc. (OTC: GALT) today announced that it posted a new corporate presentation video to its website, www.galectintherapeutics.com, that highlights the Company’s leadership position in developing galectin-inhibiting therapeutics to treat fibrosis and cancer. The video is narrated by Dr. Peter Traber, the Company’s President, CEO and Chief Medical Officer. “We continue to [...]

    Read more →

    Research and Markets: Bulgaria Pharmaceuticals and Healthcare Report Q4 2011 Out Now: An Appealing Target For Multinational Drugmakers

    by  • 30 September 2011 • General News

    DUBLIN–(BUSINESS WIRE)–Research and Markets (http://www.researchandmarkets.com/research/9c7822/bulgaria_pharmaceu) has announced the addition of the “Bulgaria Pharmaceuticals and Healthcare Report Q4 2011″ report to their offering. Bulgaria Pharmaceuticals and Healthcare Report provides industry professionals and strategists, corporate analysts, pharmaceutical associations, government departments and regulatory bodies with independent forecasts and competitive intelligence on Bulgaria’s pharma

    Read more →

    The National Association Of Boards Of Pharmacy And Pfizer Partner To Educate Patients About The Flood Of Counterfeit Medicines Online

    by  • 30 September 2011 • General News

    NEW YORK–(BUSINESS WIRE)–Pfizer Inc. (NYSE: PFE) and the National Association of Boards of Pharmacy® (NABP) are launching a new effort to draw attention to the risks associated with counterfeit prescription medicines and help patients learn how to safely buy medicines online. Prescription medicines are among the most counterfeited consumer goods. Worldwide sales of counterfeit medicines [...]

    Read more →

    Celldex Therapeutics to Present at Second Annual “Cancer Immunotherapy: A Long-Awaited Reality” Conference

    by  • 30 September 2011 • General News

    NEEDHAM, Mass.–(BUSINESS WIRE)–Celldex Therapeutics, Inc. (Nasdaq: CLDX) today announced that the Company will present at the Second Annual “Cancer Immunotherapy: A Long-Awaited Reality” Conference on Thursday, October 6, 2011 at the New York Academy of Medicine in New York City. The single-day conference event unites key opinion leaders, industry executives, and other stakeholders to engage [...]

    Read more →

    Walgreens Hosts Executive Client Forum for Health Systems Leaders to Share Best Practices in the Evolving Health Care Environment

    by  • 30 September 2011 • General News

    DEERFIELD, Ill.–(BUSINESS WIRE)–Representatives from leading health systems came together over the past two days to discuss evolving efforts in coordinated patient care at the first Walgreens (NYSE:WAG) (NASDAQ:WAG) Health Systems Executive Client Forum. The event featured presentations from health care thought leaders, health system representatives and Walgreens executives. Throughout the forum attendees participated in activities [...]

    Read more →